Exchange Traded Concepts LLC Grows Stock Position in Tempus AI, Inc. (NASDAQ:TEM)

Exchange Traded Concepts LLC boosted its position in Tempus AI, Inc. (NASDAQ:TEM) by 37.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 84,174 shares of the company’s stock after buying an additional 23,070 shares during the period. Exchange Traded Concepts LLC owned approximately 0.05% of Tempus AI worth $2,842,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. First Horizon Advisors Inc. purchased a new position in Tempus AI in the third quarter worth $30,000. Geode Capital Management LLC grew its stake in shares of Tempus AI by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock worth $7,537,000 after purchasing an additional 539 shares during the period. FNY Investment Advisers LLC purchased a new position in shares of Tempus AI in the 4th quarter valued at about $67,000. Vestor Capital LLC acquired a new stake in shares of Tempus AI in the third quarter valued at about $153,000. Finally, The Manufacturers Life Insurance Company boosted its holdings in Tempus AI by 10.2% during the third quarter. The Manufacturers Life Insurance Company now owns 29,789 shares of the company’s stock worth $1,686,000 after buying an additional 2,765 shares in the last quarter. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Tempus AI

In other Tempus AI news, EVP Andrew Polovin sold 51,504 shares of the stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $42.39, for a total transaction of $2,183,254.56. Following the transaction, the executive vice president now owns 246,085 shares of the company’s stock, valued at $10,431,543.15. This trade represents a 17.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Eric P. Lefkofsky sold 476,209 shares of Tempus AI stock in a transaction on Wednesday, January 22nd. The shares were sold at an average price of $49.84, for a total transaction of $23,734,256.56. Following the completion of the transaction, the chief executive officer now owns 6,502,643 shares in the company, valued at approximately $324,091,727.12. This trade represents a 6.82 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,862,758 shares of company stock worth $79,585,675 over the last quarter.

Analysts Set New Price Targets

Several equities research analysts have recently commented on TEM shares. Needham & Company LLC reissued a “buy” rating and set a $56.00 price target on shares of Tempus AI in a research note on Tuesday, January 14th. Wolfe Research started coverage on Tempus AI in a research report on Friday, December 13th. They set an “outperform” rating and a $60.00 target price on the stock. Guggenheim started coverage on Tempus AI in a research report on Monday, December 9th. They issued a “buy” rating and a $74.00 price target for the company. Piper Sandler reiterated a “neutral” rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Finally, Bank of America raised their target price on shares of Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a report on Friday, December 13th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $56.36.

Tempus AI Stock Performance

Shares of NASDAQ TEM opened at $51.40 on Friday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a 1 year low of $22.89 and a 1 year high of $79.49. The firm’s 50 day moving average price is $44.36 and its 200 day moving average price is $47.68.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.